-2d
-3d
Amendment to Annual Report (Form 10-K/A)
3/28
3/26
Evofem Reports Fourth Consecutive Year of Net Sales Growth
3/24
Investor Presentation March 2025
3/24
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
3/24
3/20
EVFM Investor Presentation February 2025
2/26
Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO
2/13